Drug application
CLEMASTINE FUMARATE (CLEMASTINE FUMARATE)
Drugs@FDA ANDA 074075 · ACTAVIS MID ATLANTIC
Key facts
| Drug name | CLEMASTINE FUMARATE |
|---|---|
| Active ingredients | CLEMASTINE FUMARATE |
| Application type | ANDA |
| Application number | 074075 |
| Company | ACTAVIS MID ATLANTIC |
| Dosage forms | SYRUP, ORAL |
| Strength | EQ 0.5MG BASE/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Oct 31, 1993 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.